In vitro assessment of Lipiodol-targeted radiotherapy for liver and colorectal cancer cell lines

@inproceedings{AlMufti1999InVA,
  title={In vitro assessment of Lipiodol-targeted radiotherapy for liver and colorectal cancer cell lines},
  author={Ragheed Al-Mufti and Rosmund Barbara Pedley and Damian Marshall and Richard H. J. Begent and Andrew J. W. Hilson and Marc C. Winslet and Kathryn F Hobbs},
  booktitle={British Journal of Cancer},
  year={1999}
}
SummaryIntra-arterial Lipiodol has been used to deliver targeted therapies to primary, and some metastatic, liver cancers. Targeted radiotherapy has been used by substituting the iodine in Lipiodol with 131Iodine (131I). Early clinical results are encouraging, but the variable response may partly depend on local pharmacokinetics. This study evaluated the in vitro cytotoxic effects of 131I-Lipiodol on human hepatocellular carcinoma (Hep-G2), human colorectal metastatic cancer (SW620), human… CONTINUE READING